Shimadzu Europe
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: E-News

E-News

Shimadzu Dr Frank Streit

Shimadzu, University Medical Center Göttingen team up to develop new clinical LC-MS methods for more rapid, flexible TDM analysis

, 9 November 2022/in E-News /by panglobal

Shimadzu is embarking on a new collaboration with the University Medical Center Göttingen (UMG) which will focus on the development of new clinical laboratory methods using liquid chromatography – mass spectrometry (LC-MS) for therapeutic drug monitoring (TDM) analysis.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/Shimadzu_Dr-Frank-Streit.jpg 662 1040 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-09 07:51:272022-11-09 07:51:27Shimadzu, University Medical Center Göttingen team up to develop new clinical LC-MS methods for more rapid, flexible TDM analysis
greiner EcoVadis

Greiner Bio-One achieves good results with sustain­ability assessment

, 9 November 2022/in E-News /by panglobal

Greiner Bio-One had its sustainability efforts evaluated for the first time for the entire Group through the EcoVadis platform and was awarded the silver medal for its commitment. The Greiner Bio-One Group achieved 60 out of 100 points. With this overall rating, the company group ranks among the top 20% of all companies evaluated. Greiner […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/greiner_EcoVadis-e1680866394410.jpg 900 1350 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-09 07:47:122022-11-09 07:47:12Greiner Bio-One achieves good results with sustain­ability assessment
sphere fluidocs granta park

Sphere Fluidics opens new lab facilities at Granta Park, UK

, 9 November 2022/in E-News /by panglobal

Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, has opened a new state-of-the-art facility in Granta Park, Cambridgeshire, UK, to support the company’s growth. Doubling overall capacity, the laboratories enable the team’s accelerated expansion, and the development of new, innovative products.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/sphere_fluidocs_granta_park.png 1128 1778 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-09 07:44:242022-11-09 07:44:24Sphere Fluidics opens new lab facilities at Granta Park, UK
shutterstock 1924512605

Navigo, Mannin agree to develop affinity ligand against a novel drug for treatment of COVID-19

, 8 November 2022/in E-News /by panglobal

Navigo Proteins, a premier protein engineering company and developer of affinity ligands for custom chromatography solutions and Mannin, a subsidiary of Mannin Research Inc. (MRI), have agreed to develop a Precision X affinity ligand against the fusion protein of Angiopoietin-1 and Complement 4 Binding Protein (ANG1-C4BP) for use in GMP manu­facturing. Mannin, and its parent […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/shutterstock_1924512605-scaled-e1680866408731.jpg 900 1600 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-08 19:33:552022-11-08 19:33:55Navigo, Mannin agree to develop affinity ligand against a novel drug for treatment of COVID-19
ZiathEpromo2022J image

Ziath issues guide for common 2D barcode scanning problems and how to prevent them

, 8 November 2022/in E-News /by panglobal

2D barcoded tubes are a de facto standard for high integrity sample management. However, while 2D barcoded tubes offer excellent performance, to get the most from them requires a good knowledge of common 2D barcode scanning problems and how to prevent them. A 20-page guide from Ziath provides informative solutions to the most encountered scanning […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/ZiathEpromo2022J-image.jpg 642 456 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-08 19:28:402022-11-08 19:28:40Ziath issues guide for common 2D barcode scanning problems and how to prevent them
image005

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

, 1 November 2022/in E-News /by panglobal

INDIANAPOLIS – (October 31, 2022) – More companies around the world continue turning to Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, for their next generation sequencing (NGS) needs with the Biomek NGeniuS System. The company continues building a robust demonstrated application library as it announces an application development agreement with […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/image005.jpg 721 647 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-01 09:55:212022-11-01 09:55:21Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System
shutterstock 607718810

New CRISPR-Cas approach permits more precise DNA cleavage

, 27 October 2022/in E-News /by panglobal

A team led by researchers at Massachusetts General Hospital (MGH) has overcome a major constraint for cutting and editing DNA by CRISPR-Cas enzymes and other technologies. The recent innovation, which is published in Nature Biotechnology [1], will simplify and expedite molecular cloning approaches and expand their utility.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/10/shutterstock_607718810-scaled-e1680866505564.jpg 900 1350 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-10-27 17:27:482022-10-27 17:27:48New CRISPR-Cas approach permits more precise DNA cleavage
Oxygen symbol

Researchers develop system for generating oxygen within cells

, 27 October 2022/in E-News /by panglobal

Oxygen is vital for life, and clinicians can provide supplemental oxygen to patients through face masks and nasal tubes, but there are no methods available for delivering oxygen directly into cells.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/10/Oxygen_symbol.png 2048 2048 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-10-27 17:24:232022-10-27 17:24:23Researchers develop system for generating oxygen within cells
shutterstock 2084522077

Japanese researchers develop method for detecting Alzheimer’s disease in the blood

, 27 October 2022/in E-News /by panglobal

Researchers from Hokkaido University and Toppan have developed a method to detect build-up of amyloid β in the brain, a characteristic of Alzheimer’s disease, from biomarkers in blood samples.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/10/shutterstock_2084522077-scaled-e1680866532344.jpg 800 1440 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-10-27 17:19:542022-10-27 17:19:54Japanese researchers develop method for detecting Alzheimer’s disease in the blood
shutterstock 350509643

Sebia acquires Zeus Scientific

, 27 October 2022/in E-News /by panglobal

Sebia, a global specialty diagnostic company providing solutions for screening and diagnostics in oncology, metabolic diseases, genetic disorders and autoimmune diseases, has acquired Zeus Scientific, an in vitro diagnostic (IVD) company based in New Jersey, U.S., specialized in autoimmune and infectious diseases techno- logies. Financial terms of the agreement are undisclosed.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/10/shutterstock_350509643.jpg 770 1181 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-10-27 14:20:362022-10-27 14:20:36Sebia acquires Zeus Scientific
Page 48 of 227«‹4647484950›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

November 2025

CLi Cover nov 2025
13 November 2025

New Chromsystems Product for Antiepileptic Drugs Testing

11 November 2025

Trusted analytical solutions for reliable results

10 November 2025

Chromsystems | Therapeutic Drug Monitoring by LC-MS/MS

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription